Case Report

Delirium Following Oral Single-Dose Biperiden

Volume: 5 Number: 2 June 30, 2020
EN

Delirium Following Oral Single-Dose Biperiden

Abstract

Anticholinergic drug use is one known cause of delirium. Biperiden which is an anticholinergic drug is shown to cause delirium in experimental studies and some case reports. But these reports shows great amount of biperiden use or parenteral therapy. In this case we report a patient developing delirium following a single oral dose of 2 mg biperiden. Although the pathophysiology of delirium is uncertain, we think that the cause of delirium in this patient was biperiden blocking the M1 receptors in the cerebral cortex and striatum.

Keywords

References

  1. Wilber ST, Ondrejka JE. Altered Mental Status and Delirium. Emerg Med Clin North Am. 2016;34(3):649-65.
  2. Rojo-Sanchis AM, Velez-Diaz-Pallares M, Munoz Garcia M, Delgado Silveira E, Bermejo Vicedo T, Cruz Jentoft A. Anticholinergic burden and delirium in elderly patients during acute hospital admission. Rev Esp Geriatr Gerontol. 2016;51(4):217-20.
  3. Tamura Y, Chiba S, Takasaki H, Tabata K, Ishimaru Y, Ishimoto T. Biperiden-induced delirium model in rats: a behavioral and electroencephalographic study. Brain Res. 2006;1115(1):194-9.
  4. Hewer W, Biedert S. Delirium syndrome in biperiden poisoning. Fortschr Neurol Psychiatr. 1988;56(4):133-6.
  5. Espi Martinez F, Espi Forcen F, Shapov A, Martinez Moya A. Biperiden Dependence: Case Report and Literature Review. Case Reports in Psychiatry. 2012;2012:3.

Details

Primary Language

English

Subjects

​Internal Diseases

Journal Section

Case Report

Authors

Publication Date

June 30, 2020

Submission Date

February 3, 2020

Acceptance Date

June 9, 2020

Published in Issue

Year 2020 Volume: 5 Number: 2

APA
Eryiğit, U. (2020). Delirium Following Oral Single-Dose Biperiden. Journal of Immunology and Clinical Microbiology, 5(2), 82-84. https://izlik.org/JA22AJ98SX
AMA
1.Eryiğit U. Delirium Following Oral Single-Dose Biperiden. J Immunol Clin Microbiol. 2020;5(2):82-84. https://izlik.org/JA22AJ98SX
Chicago
Eryiğit, Umut. 2020. “Delirium Following Oral Single-Dose Biperiden”. Journal of Immunology and Clinical Microbiology 5 (2): 82-84. https://izlik.org/JA22AJ98SX.
EndNote
Eryiğit U (June 1, 2020) Delirium Following Oral Single-Dose Biperiden. Journal of Immunology and Clinical Microbiology 5 2 82–84.
IEEE
[1]U. Eryiğit, “Delirium Following Oral Single-Dose Biperiden”, J Immunol Clin Microbiol, vol. 5, no. 2, pp. 82–84, June 2020, [Online]. Available: https://izlik.org/JA22AJ98SX
ISNAD
Eryiğit, Umut. “Delirium Following Oral Single-Dose Biperiden”. Journal of Immunology and Clinical Microbiology 5/2 (June 1, 2020): 82-84. https://izlik.org/JA22AJ98SX.
JAMA
1.Eryiğit U. Delirium Following Oral Single-Dose Biperiden. J Immunol Clin Microbiol. 2020;5:82–84.
MLA
Eryiğit, Umut. “Delirium Following Oral Single-Dose Biperiden”. Journal of Immunology and Clinical Microbiology, vol. 5, no. 2, June 2020, pp. 82-84, https://izlik.org/JA22AJ98SX.
Vancouver
1.Umut Eryiğit. Delirium Following Oral Single-Dose Biperiden. J Immunol Clin Microbiol [Internet]. 2020 Jun. 1;5(2):82-4. Available from: https://izlik.org/JA22AJ98SX

88x31.png 

Creative Commons Attribution Non-Commercial License: The articles in the Journal of Immunology and Clinical Microbiology are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

JICM is a product of QMEL® medicine & publishing